<< Read Full Article
<< Read Full Article
Pharmion's Loss Widens, but Sales Rise
Pharmion(PHRM Quote) reported a third-quarter loss Wednesday, but revenue beat expectations and the company raised full-year guidance.
The company reported a net loss of $21.4 million, or 58 cents a share, compared with a loss of $3.6 million, or 11 cents a share in the year-ago quarter.
Pharmion's quarter included a charge of $8 million for a milestone payment triggered by the acceptance of its marketing application for cancer drug Satraplatin by the European Medicines Agency. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,309.92 | 1,091.49 | 2,138.44 | 32.31 |
Oil *
77.12
|
|
DOWN
154.48
|
DOWN
19.14
|
DOWN
37.61
|
DOWN
0.48
|
10 Yr
3.23%
SPDR Gold
115.06
|
|
-1.48%
|
-1.72%
|
-1.73%
|
-1.46%
|
Data delayed 20 minutes |
Connect with TheStreet